IL10 and irritable bowel syndrome: Considering the key role of microorganisms in the intestinal microecological balance and IBD inflammatory characteristics, an anti-inflammatory cytokine, interleukin-10, was expressed in Lactobacillus to treat chronic disease, which finally led to a 50% therapeutic efficacy in a mouse IBD model (Steidler et al., 2000).